Anti-inflammatory dihydroxanthones from a Diaporthe species

Biol Chem. 2021 Aug 2;403(1):89-101. doi: 10.1515/hsz-2021-0192. Print 2022 Jan 26.

Abstract

In a search for anti-inflammatory compounds from fungi inhibiting the promoter activity of the small chemokine CXCL10 (Interferon-inducible protein 10, IP-10) as a pro-inflammatory marker gene, the new dihydroxanthone methyl (1R, 2R)-1,2,8-trihydroxy-6-(hydroxymethyl)-9-oxo-2,9-dihydro-1H-xanthene-1-carboxylate (2) and the previously described dihydroxanthone AGI-B4 (1) were isolated from fermentations of a Diaporthe species. The structures of the compounds were elucidated by a combination of one- and two-dimensional NMR spectroscopy, mass spectrometry, and calculations using density functional theory (DFT). Compounds 1 and 2 inhibited the LPS/IFNγ induced CXCL10 promoter activity in transiently transfected human MonoMac6 cells in a dose-dependent manner with IC50 values of 4.1 µM (±0.2 µM) and 1.0 µM (±0.06 µM) respectively. Moreover, compounds 1 and 2 reduced mRNA levels and synthesis of pro-inflammatory mediators such as cytokines and chemokines in LPS/IFNγ stimulated MonoMac6 cells by interfering with the Stat1 and NFκB pathway.

Keywords: CXCL10; dihydroxanthones; inflammation; inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents* / pharmacology
  • Ascomycota / chemistry*
  • Chemokine CXCL10*
  • Cytokines
  • Humans
  • Interferon-gamma
  • NF-kappa B

Substances

  • Anti-Inflammatory Agents
  • Chemokine CXCL10
  • Cytokines
  • NF-kappa B
  • Interferon-gamma